Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Completed · Not applicable
Conditions studied: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
In brief
The purpose of this research study is to collect tumor samples at the time of surgery and store them for possible use as part of an experimental vaccine study for the participants cancer in the future.
Key facts
- Study ID
- NCT00801320
- Run by
- Beth Israel Deaconess Medical Center
- People needed
- 100
- Starts
- 2008-09-01
- Expected to finish
- 2020-08-01
- Last updated by the study team
- 2020-09-10
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Clinical suspicion of advanced ovarian, fallopian tube or primary peritoneal cancer as determined by a gynecologic oncologist
- Patients are planning to undergo primary or secondary debulking surgery as part of standard of care for their disease
- Estimated life expectancy of 6 months or greater
- 18 years of age or older
You may not qualify if…
- More than one prior chemotherapy regimen
- Serious intercurrent illness such as infection requiring IV antibiotics, or significant cardiac disease characterized by significant arrhythmia, unstable ischemic coronary disease or congestive heart failure
- Known HIV infection
- Active second malignancy, aside from basal cell or squamous cell carcinoma of the skin
- Significant autoimmune disease, including psoriasis
- History of clinically significant venous thromboembolism
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Brigham & Women's Hospital — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.